Key Updates from Major Pharmaceutical Companies: Amylyx, Sanofi, Novartis, Roche, and Eisai
Here’s a quick rundown of recent news from major pharmaceutical companies that you might have missed. Amylyx Pharmaceuticals announced that […]
Here’s a quick rundown of recent news from major pharmaceutical companies that you might have missed. Amylyx Pharmaceuticals announced that […]
Starting in January 2026, the NHS in England will provide the chickenpox vaccine to children as part of their routine
A major study by Eli Lilly has found that patients with early-stage breast cancer who took Verzenio along with standard
Novo Nordisk, the company behind popular weight loss and diabetes drugs Ozempic and Wegovy, is teaming up with Replicate Bioscience
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the
Xoma Royalty Corp. has agreed to buy Mural Oncology, a biotech company focused on cancer treatments, for $2.035 per share.
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working
Over the next five years, many top-selling cancer drugs from major pharmaceutical companies will lose their patent protection. This is
A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans
Measuring how long a cancer treatment extends life (overall survival, or OS) is the best way to judge its effectiveness.